Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00973349 · ClinicalTrials.gov registry record · Phase 2
Safety and Immunogenicity of A/H1N1-SOIV (Swine Flu) Vaccine With and Without Adjuvant in Non-Elderly and Elderly Adults
A Phase 2 study, sponsored by Novartis.
- Completed
- Registry status
- Phase 2
- Development phase
- 2,719
- Enrollment target
NCT00973349 is a Phase 2 study that has completed, run by Novartis. The registered enrollment target is 2,719 participants.
The verdict
NCT00973349, a Phase 2 study, has completed, sponsored by Novartis.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 2,719 participants
- Enrollment target
Study Summary
This study will evaluate the safety and immunogenicity of different combinations of A/H1N1 S-OIV (swine flu) vaccine in non-elderly and elderly adults.
Interventions
- BIOLOGICAL MF59-eH1N1_f
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,719 participants |
| Start Date | 2009-09 |
| Est. Completion | 2010-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00973349
The ClinicalTrials.gov registry entry for NCT00973349 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 2,719 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Novartis, which has 265 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MF59-eH1N1_f is the first listed.
NCT00973349 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00973349 about?
NCT00973349 is a clinical study titled "Safety and Immunogenicity of A/H1N1-SOIV (Swine Flu) Vaccine With and Without Adjuvant in Non-Elderly and Elderly Adults". This study will evaluate the safety and immunogenicity of different combinations of A/H1N1 S-OIV (swine flu) vaccine in non-elderly and elderly adults.
What is the current status of trial NCT00973349?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 2,719 participants. The study started on 2009-09. Estimated completion is 2010-12.
What interventions are being tested in trial NCT00973349?
The interventions under investigation include: MF59-eH1N1_f (BIOLOGICAL).
Who is sponsoring clinical trial NCT00973349?
This trial is sponsored by Novartis, which has 265 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.